Emergent BioSolutions <a href="https://www.reuters.com/markets/companies/EBS.N" target="_blank">(EBS.N)</a> on Tuesday decided to cut 400 jobs and scale back operations at some its facilities, pivoting its focus on core products such as overdose reversal nasa…